A field note should let another person understand exactly what was observed. In this case the documented offer is Hims Daily Hard Mints, meaning a daily tadalafil Hard Mints listing on the dedicated chewable page. The review keeps product identity, advertised terms and open questions in separate entries. It is a record of public information, not a report from a patient visit.
Availability: Listed on the dedicated chewable-medicine page; confirm current plan.
The exact product
The distinguishing observation is a daily regimen and the current identity of an older public offer. Record the full active list and supplied form before summarizing the product as a pill, chew or ED treatment. Those short categories lose information that may matter to a pharmacist. A later prescription can differ from the listing, so keep the advertised record and the dispensed label identifiable. Neither should silently replace the other in a treatment history.
| Provider | Hims |
|---|---|
| Listed active ingredients | Tadalafil; confirm the dispensed formula |
| Dosage form | Compounded daily mint |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Hims: Hard Mints chewable ED medicines · Hims: current ED treatment catalog |
Price, supply and payment
The price observation is From $39/month on the chewable page. Attach a quantity and billing period only where the source provides them together. Keep any calculated monthly equivalent separate from the actual payment schedule. If the figure is approximate, a starting price or unmatched to a complete plan, preserve that qualifier. A useful financial note shows the limit of the observation instead of making the blank fields look complete.
| Dedicated page headline | From $39/month |
|---|---|
| Catalog distinction | The main catalog separately lists newer named chews |
| Confirmation needed | Complete dispensed ingredients and current plan |
| Schedule distinction | Daily does not mean adding an occasion-based ED product independently |
What the research can support
The evidence entry reads: daily tadalafil research rather than a trial of every mint formulation. The unanswered part is whether this exact offer remains selectable for the account. Record the studied population, preparation and outcome before linking research to a commercial product. An abstract can establish what its authors reported while leaving methods unavailable for full appraisal. A provider's own survey belongs in a different category from a randomized comparison; a field note should make that source difference easy to see.
| Evidence boundary | daily tadalafil research rather than a trial of every mint formulation |
|---|---|
| Not established here | whether this exact offer remains selectable for the account |
| Clinical and regulatory references | MedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil |
Safety questions for the prescriber
Use the medication list as a reconciliation document. It should include nitrate or nitrite use, riociguat, other ED treatments, blood-pressure drugs and relevant medical conditions. Do not mark Hims Daily Hard Mints as cleared merely because a prior ED drug was tolerated. The clinician must consider the actual formula and history. Record the instructions received rather than deriving a dose, overlap or switching interval from this review.
| One active does not mean no interactions | Nitrates/nitrites, riociguat and other medications require assessment even after previous ED treatment. |
|---|
Availability and the actual prescription
The access observation is time-specific: Listed on the dedicated chewable-medicine page; confirm current plan. Distinguish a public catalog entry, a safety-library entry, an account offer and a clinician-approved prescription. They are four different states. If support supplies a clarification, save the date and exact product name. A link that opens successfully proves only that a page is reachable, not that enrollment or dispensing has been verified.
Refills, changes and cancellation
When the plan changes, create a new entry rather than overwriting the old one. Note who advised the change, which prescription it concerns and what happens to the next order. A useful question to carry forward is “Is the daily product offered to me the same formulation as this public listing?” Keep clinical response notes separate from shipment and payment confirmations. This makes it easier to identify an unresolved handoff before a refill proceeds on outdated assumptions.
| Next charge | The next order date is the charge/processing date; a first refill can be scheduled early. |
|---|---|
| Cancellation notice | At least 48 hours before the next order, according to support guidance. |
| Already processing | Ending a subscription does not cancel an order already processing or shipped. |
| Refund boundary | No refund guaranteed after pharmacy processing. |
| Policy sources | Hims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs |
Compare named products
The related reviews serve as cross-references, not endorsements. Compare a named field such as active list, dosage form or payment term and state why the difference matters. Do not infer a matching strength from a similar product name. If a proposed alternative has an unverified current plan, retain that uncertainty in the comparison instead of treating the alternative as immediately obtainable.
Questions to keep with the offer
The final field is the boundary of the investigation. We read the cited documents but did not order Hims Daily Hard Mints, inspect a pharmacy, test support or observe clinical outcomes. That boundary belongs in the record as much as the ingredients do. New account or prescribing information can update the practical decision; it does not retroactively turn this public-document review into a firsthand assessment.
| Ask about this formula | Is the daily product offered to me the same formulation as this public listing? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Trace the information
Checked October 7, 2026. Provider pages establish advertised claims. Medical sources supply general context; citation does not imply endorsement.
- Hims: Hard Mints chewable ED medicinesProvider source; compounded formulations and advertised starting prices
- Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices
- Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing
- Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing
- Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals
- Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- MedlinePlus: SildenafilDrug information; standard sildenafil products